Background
==========

Breast cancer is a common tumor in women, with \~279 100 new cases and 42 690 deaths in 2020 alone \[[@b1-medscimonit-26-e923630]\]. Infiltrating ductal carcinoma of breast cancer (IDC) accounts for \~70--80% of breast cancers globally \[[@b2-medscimonit-26-e923630],[@b3-medscimonit-26-e923630]\]. Although advances in treatment have reduced the mortality rate of IDC, the increasing incidence of IDC is still a serious problem \[[@b4-medscimonit-26-e923630]\]. Therefore, it is urgent to explore potential risk factors contributing to IDC development. The risk factors for breast cancer include reproductive risk factors \[[@b5-medscimonit-26-e923630]\], lifestyle \[[@b6-medscimonit-26-e923630]\], family history \[[@b7-medscimonit-26-e923630]\], and genetic predisposition \[[@b8-medscimonit-26-e923630]\]. Psychological and social factors are also emerging as key indicators of cancer development \[[@b9-medscimonit-26-e923630]\].

Marital status is a key sociocultural variable that influences cancer patients. Marital status can predict the outcomes of rectal cancer \[[@b10-medscimonit-26-e923630]\], ovarian serous carcinoma \[[@b11-medscimonit-26-e923630]\], pancreatic cancer \[[@b12-medscimonit-26-e923630]\], and non-small cell lung cancer \[[@b13-medscimonit-26-e923630]\]. Similarly, marital status has been suggested as a predictive factor for breast cancer survival \[[@b14-medscimonit-26-e923630]--[@b17-medscimonit-26-e923630]\]. Breast cancer is highly heterogeneous, with a range of pathologies, biological behavior, and prognosis that differ from other histological subtypes \[[@b18-medscimonit-26-e923630],[@b19-medscimonit-26-e923630]\]. However, most previous reports did not distinguish histologic subtypes or molecular subtypes. In addition, significant imbalances in baseline characteristics exist amongst the studied groups based on marital status. The effects of marital status on the prognosis of IDC patients therefore require assessment.

In this study, 1: 1 propensity score matching (PSM) was performed to explore the influence of marital status on IDC prognosis in the Surveillance, Epidemiology, and End Results (SEER) database.

Material and Methods
====================

Patients
--------

The SEER 18 regions database \[Incidence-SEER 18 Regs Research Data (with additional treatment fields), Nov 2017 Sub (1975--2016 varying)\] was used, encompassing \~28% of the U.S. population. Patients diagnosed from 2010 to 2015 were collected due to the lack of availability of Her2 information prior to 2010. Inclusion criteria were as follows: (1) age ≥18 years at diagnosis; (2) accessible marital information; (3) histology ICD-O-3 (International Classification of Diseases for Oncology, 3^rd^ edition) limited to infiltrating duct carcinoma (8500/3); and (4) survival times ≥1 month. Patients with missing or incomplete demographic, clinicopathological, treatment, or follow-up information were excluded.

Clinicopathological variables
-----------------------------

Marital status, gender, age at diagnosis, ethnicity, median household income, insurance status, tumor grade, tumor size, lymph node, metastasis, TNM stage, ER, PR, Her2, molecular subtype, treatment regimens, and prognostic information were assessed. Patients were divided into those who were married, single, divorced, and widowed based on marital status. Age was categorized as 18--49 years, 50--59 years, 60--69 years, 70--79 years, and ≥80 years. Ethnicity was classified into white, black, American Indian/Alaska Native (AI), and Asian or Pacific Islander (API). Socioeconomic status was divided into Quartile 1 (\<\$52 620), Quartile 2 (\$52 621--\$60 890), Quartile 3 (\$60 891--\$74 440), and Quartile 4 (\>\$74 441). Tumor grade IV was combined with grade III. TNM staging was performed according to the 7^th^ edition of the American Joint Committee on Cancer (AJCC) and classed into stage I to stage IV. Radiation and chemotherapy were categorized as "yes" and "no/unknown".

Statistical analyses
--------------------

Baseline features were compared using the chi-square test. The primary endpoints were overall survival (OS) and breast cancer-specific survival (BCSS). Kaplan-Meier (KM) curves were used to investigate survival differences amongst the groups. Log-rank tests were applied for group comparisons. Prognostic factors were identified using multivariate Cox proportional hazard assessments.

PSM can reduce selection bias and mimic randomized controlled trials \[[@b20-medscimonit-26-e923630],[@b21-medscimonit-26-e923630]\], and was employed to reassess the influence of marital status. PSM was performed using 1: 1 nearest neighbor matching with a caliper of 0.01. Standardized differences (SD) were used to assess the changes in variables before and after PSM. SD ≤0.1 were employed to denote significant balances in the baseline covariate \[[@b22-medscimonit-26-e923630]\].

Statistical analyses were performed using R (version 3.5.2, *<https://www.r-project.org/>*). R packages, including tableone, rms, survival, survminer, ggplot2, cobalt, and MatchIt, were used. Assessments were 2-sided. P-value \<0.05 was deemed statistically significant.

Results
=======

Clinicopathological characteristics
-----------------------------------

From 2010 to 2015, 183 260 patients with IDC were included. Clinicopathological characteristics in each group are presented in [Table 1](#t1-medscimonit-26-e923630){ref-type="table"}. Those who were widowed tended to be in the older age groups of 60--69 (22.8%), 70--79 (33.9%), and ≥80 years (33.8%). The single group had more black patients (23.4%), while the married group had more Asian/Pacific Islander patients (7.1%). Compared to those who were divorced, single, and widowed, married patients tended to have earlier stage (53.4%), smaller tumor sizes (62.6%), negative lymph nodes (67.5%), and no metastasis (97.1%). Patients in the widowed group were least likely to have received radiation (45.3%) or chemotherapy (25.4%).

Effects of marital status on OS and BCSS
----------------------------------------

The OS and BCSS of patients with IDC were assessed using Kaplan-Meier analysis. Significant differences in OS were observed based on marital status (p\<0.0001) ([Figure 1A](#f1-medscimonit-26-e923630){ref-type="fig"}). The 5-year OS was 89.6% in married patients, and 71.3%, 84.9%, and 83.5% in those who were widowed, single, and divorced, respectively ([Table 2](#t2-medscimonit-26-e923630){ref-type="table"}). The BCSS of the 4 marital subgroups also differed ([Figure 1B](#f1-medscimonit-26-e923630){ref-type="fig"}). The 5-year BCSS was 92.9% in the married group, 90.2% in the divorced group, 87.6% the single group, and 86.4% in the widowed group (p\<0.001) ([Table 3](#t3-medscimonit-26-e923630){ref-type="table"}).

Univariate analysis demonstrated that ethnicity, age, gender, income, insurance status, tumor grade, stage, subtype, surgical therapy, radiation therapy, and chemotherapy were significantly associated with OS ([Table 2](#t2-medscimonit-26-e923630){ref-type="table"}) and BCSS ([Table 3](#t3-medscimonit-26-e923630){ref-type="table"}) (all p\<0.001).

Results from multivariate Cox regression analysis revealed marriage as a protective factor for OS (divorced: HR, 1.27; 95% CI, 1.21--1.32; p\<0.001; single: HR, 1.36; 95% CI, 1.31--1.42; p\<0.001; and widowed: HR, 1.42; 95% CI, 1.36--1.48; p\<0.001) ([Table 2](#t2-medscimonit-26-e923630){ref-type="table"}) and BCSS (divorced: HR, 1.15; 95% CI, 1.09--1.21; p\<0.001; single: HR, 1.27; 95% CI, 1.21--1.33; p\<0.001; and widowed: HR, 1.32; 95% CI, 1.25--1.40; p\<0.001) ([Table 3](#t3-medscimonit-26-e923630){ref-type="table"}) in patients with IDC. Molecular subtype, insurance, surgery, radiation therapy, and chemotherapy showed a highly significant association with OS and BCSS.

To reduce the effect of confounders, IDC patients were stratified according to clinical features. We also identified marital status as an independent prognostic indicator of OS ([Figure 2](#f2-medscimonit-26-e923630){ref-type="fig"}) and BCSS ([Figure 3](#f3-medscimonit-26-e923630){ref-type="fig"}) in all subgroups.

Survival analysis after 1: 1 PSM
--------------------------------

To minimize the confounding factors and assess the impact of marital status, we performed 1: 1 PSM. Three 1: 1 matched cohorts were obtained: a divorced and married cohort, a single and married cohort, and a widowed and married cohort. The demographic and clinicopathological features between 2 groups in the 2 cohorts were balanced ([Table 4](#t4-medscimonit-26-e923630){ref-type="table"}). The absolute mean differences in all variables across the groups were less than 0.1 following PSM assessment ([Figure 4](#f4-medscimonit-26-e923630){ref-type="fig"}). Married patients showed better BCSS and OS in the divorced-married cohort ([Figure 5A, 5B](#f5-medscimonit-26-e923630){ref-type="fig"}), the single-married cohort ([Figure 5C, 5D](#f5-medscimonit-26-e923630){ref-type="fig"}), and the widowed-married cohort ([Figure 5E, 5F](#f5-medscimonit-26-e923630){ref-type="fig"}).

Discussion
==========

This is the first study to investigate the influence of marital status on IDC prognosis using PSM in the SEER database. In comparison to previous SEER-based studies, we particularly assessed significant covariates, including molecular subtype, household income, and insurance. We found that 4 marital subgroups showed different survival outcomes for OS and BCSS. In multivariate Cox analysis encompassing an integrated range of variables, we demonstrated that marriage was an independent prognostic and protective factor for OS and BCSS, and widowed patients were the most likely to die of IDC. After PSM, we further confirmed that those who married showed better OS and BCSS compared to the divorced, single or widowed patients.

These findings raise the intriguing question of why married patients showed better clinical outcomes. One hypothesis is the higher likelihood for early diagnosis in those who are married. Studies have shown that delayed diagnosis can lead to poor survival of unmarried patients \[[@b17-medscimonit-26-e923630],[@b23-medscimonit-26-e923630],[@b24-medscimonit-26-e923630]\]. In the present study, widowed patients tended to be older than married patients. The incidence of metastasis was lower in the married group (2.9%) compared to the divorced (4.2%), single (5.3%), and widowed (4.0%) groups. Spouses might facilitate early IDC diagnosis, leading to better prognosis.

Secondly, married patients tended to have more financial resources and better access to effective treatment \[[@b25-medscimonit-26-e923630],[@b26-medscimonit-26-e923630]\]. Spouses and their children may provide financial assistance that is unavailable to single, divorced, or widowed patients \[[@b27-medscimonit-26-e923630]\]. Our research indicated that compared with married patients, those who were widowed, single, or divorced tended to be undertreated, which may have contributed to their worse prognosis \[[@b28-medscimonit-26-e923630]\].

Thirdly, married patients might obtain extra psychological and emotional support from their spouse and children, which can improve disease outcomes \[[@b29-medscimonit-26-e923630]\]. A cancer diagnosis was reported to cause higher levels of psychological distress than that of other chronic diseases \[[@b30-medscimonit-26-e923630]\]. In addition, compared to married patients, the single, divorced, and widowed patients were more likely to have depression and anxiety after a diagnosis of cancer \[[@b31-medscimonit-26-e923630]\]. Stress and depression combined had an association with immune dysfunction, nonadherence to medical advice, and tumor progression \[[@b32-medscimonit-26-e923630],[@b33-medscimonit-26-e923630]\]. Emotional assistance can improve the quality of life, thereby preventing disease-associated decline in breast cancer patients \[[@b34-medscimonit-26-e923630],[@b35-medscimonit-26-e923630]\]. Therefore, the benefits of psychosocial support should not be underestimated for single, divorced, and widowed populations. It is vital that physicians screen for such distress and provide psychosocial support interventions as required.

Fourthly, it was reported that married people have healthier lifestyle behaviors \[[@b36-medscimonit-26-e923630]\]. The single, divorced, and widowed patients were more likely have unhealthy lifestyles, such as heavy drinking and smoking, which can adversely affect overall survival of breast cancer patients \[[@b37-medscimonit-26-e923630],[@b38-medscimonit-26-e923630]\]. This may partly explain the better prognosis in those who are married.

Some limitations of the present study should be discussed. Firstly, reproductive history and comorbidities were not included in the SEER database. These missing factors associated with prognosis may lead to potential bias. Secondly, the SEER database records marital status at diagnosis, but we lacked detailed information on the quality of marriage, the subsequent changes in marital status, and other marital statuses, including gay, lesbian, bisexual, and transgender. Finally, given the retrospective nature of our analysis, further prospective studies are required.

Conclusions
===========

This study, which had a large sample and used ingenious statistical analyses, found that married status was a protective prognostic factor for IDC patients. The single, divorced, and widowed patients were at higher risk of undertreatment, metastasis, and poor outcomes. Widowed patients had the highest mortality rates. Targeted psychosocial support should now be provided to these IDC patient subsets.
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###### 

The characteristics of patients with breast cancer according to marital status in the SEER database.

  Characteristic                 Married         Divorced       Single          Widowed        pvalue
  ------------------------------ --------------- -------------- --------------- -------------- ---------
  Subtype (%)                                                                                  
   HR−/HER2− (triple negative)   13281 (12.3)    3099 (13.6)    4247 (14.4)     2668 (11.6)    \<0.001
   HR−/HER2+ (HER2 enriched)     5801 (5.4)      1217 (5.3)     1636 (5.5)      1063 (4.6)     
   HR+/HER2− (Luminal A)         75459 (69.9)    15806 (69.2)   19598 (66.4)    17097 (74.3)   
   HR+/HER2+ (LuminalB)          13358 (12.4)    2704 (11.8)    4054 (13.7)     2172 (9.4)     
  Age (%)                                                                                      
   18--49                        28875 (26.8)    4655 (20.4)    10349 (35.0)    440 (1.9)      \<0.001
   50--59                        30248 (28.0)    6646 (29.1)    8601 (29.1)     1728 (7.5)     
   60--69                        29621 (27.5)    7127 (31.2)    6773 (22.9)     5251 (22.8)    
   70--79                        14942 (13.8)    3438 (15.1)    2762 (9.4)      7806 (33.9)    
   ≥80                           4213 (3.9)      960 (4.2)      1050 (3.6)      7775 (33.8)    
  Race (%)                                                                                     
   White                         87818 (81.4)    17685 (77.5)   19926 (67.5)    18499 (80.4)   \<0.001
   Black                         7669 (7.1)      3601 (15.8)    6915 (23.4)     2709 (11.8)    
   API                           11850 (11.0)    1381 (6.1)     2440 (8.3)      1672 (7.3)     
   AI                            562 (0.5)       159 (0.7)      254 (0.9)       120 (0.5)      
  Gender (%)                                                                                   
   Male                          990 (0.9)       114 (0.5)      239 (0.8)       74 (0.3)       \<0.001
   Female                        106909 (99.1)   22712 (99.5)   29296 (99.2)    22926 (99.7)   
  Median household income (%)                                                                  
   Quartile1                     27103 (25.1)    6644 (29.1)    7528 (25.5)     7309 (31.8)    \<0.001
   Quartile2                     26289 (24.4)    5551 (24.3)    8608 (29.1)     5554 (24.1)    
   Quartile3                     26613 (24.7)    5634 (24.7)    6145 (20.8)     5307 (23.1)    
   Quartile4                     27894 (25.9)    4997 (21.9)    7254 (24.6)     4830 (21.0)    
  Insurance (%)                                                                                
   Insured                       106504 (98.7)   22291 (97.7)   28505 (96.5)    22800 (99.1)   \<0.001
   Uninsured                     1395 (1.3)      535 (2.3)      1030 (3.5)      200 (0.9)      
  Grade (%)                                                                                    
   I                             22865 (21.2)    4636 (20.3)    5175 (17.5)     5039 (21.9)    \<0.001
   II                            45042 (41.7)    9290 (40.7)    11695 (39.6)    10280 (44.7)   
   III                           39992 (37.1)    8900 (39.0)    12665 (42.9)    7681 (33.4)    
  Stage (%)                                                                                    
   I                             57607 (53.4)    11354 (49.7)   12855 (43.5)    11995 (52.2)   \<0.001
   II                            36396 (33.7)    7871 (34.5)    10999 (37.2)    7671 (33.4)    
   III                           10732 (9.9)     2653 (11.6)    4104 (13.9)     2415 (10.5)    
   IV                            3164 (2.9)      948 (4.2)      1577 (5.3)      919 (4.0)      
  Tumor size (%)                                                                               
   T0/1                          67595 (62.6)    13348 (58.5)   15363 (52.0)    13685 (59.5)   \<0.001
   T2                            32257 (29.9)    7275 (31.9)    10237 (34.7)    7134 (31.0)    
   T3                            5121 (4.7)      1258 (5.5)     2261 (7.7)      1023 (4.4)     
   T4                            2926 (2.7)      945 (4.1)      1674 (5.7)      1158 (5.0)     
  Node status (%)                                                                              
   N0                            72833 (67.5)    14922 (65.4)   18271 (61.9)    16259 (70.7)   \<0.001
   N1                            26627 (24.7)    5760 (25.2)    8092 (27.4)     4922 (21.4)    
   N2                            5422 (5.0)      1375 (6.0)     1980 (6.7)      1141 (5.0)     
   N3                            3017 (2.8)      769 (3.4)      1192 (4.0)      678 (2.9)      
  Metastasis (%)                                                                               
   M0                            104735 (97.1)   21878 (95.8)   27958 (94.7)    22081 (96.0)   \<0.001
   M1                            3164 (2.9)      948 (4.2)      1577 (5.3)      919 (4.0)      
  Bone M (%)                                                                                   
   Yes                           1988 (1.8)      583 (2.6)      1015 (3.4)      532 (2.3)      \<0.001
   No                            105911 (98.2)   22243 (97.4)   28520 (96.6)    22468 (97.7)   
  Brain M (%)                                                                                  
   Yes                           177 (0.2)       60 (0.3)       98 (0.3)        51 (0.2)       \<0.001
   No                            107722 (99.8)   22766 (99.7)   29437 (99.7)    22949 (99.8)   
  Liver M (%)                                                                                  
   Yes                           840 (0.8)       237 (1.0)      401 (1.4)       198 (0.9)      \<0.001
   No                            107059 (99.2)   22589 (99.0)   29134 (98.6)    22802 (99.1)   
  Lung M (%)                                                                                   
   Yes                           927 (0.9)       298 (1.3)      501 (1.7)       376 (1.6)      \<0.001
   No                            106972 (99.1)   22528 (98.7)   29034 (98.3)    22624 (98.4)   
  ER (%)                                                                                       
   Negative                      20377 (18.9)    4596 (20.1)    6303 (21.3)     3982 (17.3)    \<0.001
   Positive                      87522 (81.1)    18230 (79.9)   23232 (78.7)    19018 (82.7)   
  PR (%)                                                                                       
   Negative                      30772 (28.5)    6946 (30.4)    9220 (31.2)     6507 (28.3)    \<0.001
   Positive                      77127 (71.5)    15880 (69.6)   20315 (68.8)    16493 (71.7)   
  HER2 (%)                                                                                     
   Negative                      88740 (82.2)    18905 (82.8)   23845 (80.7)    19765 (85.9)   \<0.001
   Positive                      19159 (17.8)    3921 (17.2)    5690 (19.3)     3235 (14.1)    
  Surgery (%)                                                                                  
   No surgery                    4341 (4.0)      1339 (5.9)     2326 (7.9)      1872 (8.1)     \<0.001
   BCS                           61159 (56.7)    12834 (56.2)   15175 (51.4)    13208 (57.4)   
   Mastectomy                    42399 (39.3)    8653 (37.9)    12034 (40.7)    7920 (34.4)    
  Radiation (%)                                                                                
   None/unknown                  46773 (43.3)    10292 (45.1)   14297 (48.4)    12574 (54.7)   \<0.001
   Yes                           61126 (56.7)    12534 (54.9)   615238 (51.6)   10426 (45.3)   
  Chemotherapy (%)                                                                             
   No/unknown                    56299 (52.2)    12055 (52.8)   14119 (47.8)    17161 (74.6)   \<0.001
   Yes                           51600 (47.8)    10771 (47.2)   15416 (52.2)    5839 (25.4)    

###### 

Impact of marital status on the OS by univariate and multivariate survival analysis before PSM.

  Characteristics                5-year OS   Univariate analysis   Multivariate analysis                             
  ------------------------------ ----------- --------------------- ----------------------- ----------- ------------- ---------
  Marital status                             4346.6                \<0.001                                           
   Married                       89.6%                                                     Reference                 
   Divorced                      84.9%                                                     1.27        1.21--1.32    \<0.001
   Single                        83.5%                                                     1.36        1.31--1.42    \<0.001
   Widowed                       71.3%                                                     1.42        1.36--1.48    \<0.001
  Age                                        9737.8                \<0.001                                           
   18--49                        89.6%                                                     Reference                 
   50--59                        89.6%                                                     3.42        3.28--3.57    \<0.001
   60--69                        88.9%                                                     1.51        1.46--1.56    \<0.001
   70--79                        82.3%                                                     1.05        1.02--1.09    0.001
   ≥80                           57.2%                                                     0.98        0.95--1.01    0.161
  Race                                       1063.9                \<0.001                                           
   White                         86.1%                                                     Reference                 
   Black                         78.4%                                                     1.24        1.19--1.29    \<0.001
   API                           91.0%                                                     0.75        0.71--0.80    \<0.001
   AI                            83.8%                                                     1.29        1.09--1.53    0.004
  Gender                                     108.6                 \<0.001                                           
   Male                          75.0%                                                     Reference                 
   Female                        85.8%                                                     0.73        0.65--0.83    \<0.001
  Median household income                    701.2                 \<0.001                                           
   Quartile 1                    82.1%                                                     Reference                 
   Quartile 2                    85.2%                                                     0.8         0.77--0.82    \<0.001
   Quartile 3                    86.8%                                                     1.01        0.98--1.04    0.473
   Quartile 4                    88.9%                                                     0.99        0.96--1.02    0.658
  Insurance                                  122.0                 \<0.001                                           
   Uninsured                     78.9%                                                     Reference                 
   Insured                       85.8%                                                     0.75        0.68--0.82    \<0.001
  Grade                                      3373.4                \<0.001                                           
   I                             92.8%                                                     Reference                 
   II                            88.0%                                                     1.24        1.17--1.30    \<0.001
   III                           79.3%                                                     1.84        1.74--1.94    \<0.001
  Stage                                      27296.3               \<0.001                                           
   I                             92.9%                                                     Reference                 
   II                            85.6%                                                     1.83        1.75--1.90    \<0.001
   III                           70.1%                                                     4.52        4.31--4.74    \<0.001
   IV                            32.3%                                                     10.28       9.72--10.88   \<0.001
  Subtype                                    3036.7                \<0.001                                           
   HR−/HER2− (triple negative)   74.3%                                                     Reference                 
   HR−/HER2+ (HER2 enriched)     81.6%                                                     0.52        0.49--0.56    \<0.001
   HR+/HER2− (Luminal A)         87.9%                                                     0.48        0.46--0.50    \<0.001
   HR+/HER2+ (Luminal B)         86.7%                                                     0.42        0.40--0.44    \<0.001
  Surgery                                    17876.6               \<0.001                                           
   No surgery                    44.0%                                                     Reference                 
   BCS                           90.8%                                                     0.42        0.40--0.44    \<0.001
   Mastectomy                    83.6%                                                     0.48        0.46--0.50    \<0.001
  Radiation                                  2212.4                \<0.001                                           
   None/unknown                  81.1%                                                     Reference                 
   Yes                           89.5%                                                     0.74        0.71--0.76    \<0.001
  Chemotherapy                               55.0                  \<0.001                                           
   No/unknown                    86.4%                                                     Reference                 
   Yes                           84.8%                                                     0.78        0.75--0.81    \<0.001

OS -- overall survival; PSM -- propensity score matching; HR -- hazard ratio; CI -- confidence interval.

###### 

Impact of marital status on the BCSS by univariate and multivariate survival analysis before PSM.

  Characteristics                5-year OS   Univariate analysis   Multivariate analysis                              
  ------------------------------ ----------- --------------------- ----------------------- ----------- -------------- ---------
  Marital status                             1200.1                \<0.001                                            
   Married                       92.9%                                                     Reference                  
   Divorced                      90.2%                                                     1.15        1.09--1.21     \<0.001
   Single                        87.6%                                                     1.27        1.21--1.33     \<0.001
   Widowed                       86.4%                                                     1.32        1.25--1.40     \<0.001
  Age                                        1228.9                \<0.001                                            
   18--49                        90.6%                                                     Reference                  
   50--59                        91.4%                                                     2.04        1.93--2.15     \<0.001
   60--69                        92.9%                                                     1.34        1.29--1.40     \<0.001
   70--79                        91.0%                                                     1.08        1.03--1.12     \<0.001
   ≥80                           82.7%                                                     0.96        0.92--1.00     0.040
  Race                                       1194.6                \<0.001                                            
   White                         91.6%                                                     Reference                  
   Black                         83.8%                                                     1.27        1.21--1.33     \<0.001
   API                           93.6%                                                     0.8         0.74--0.86     \<0.001
   AI                            89.5%                                                     1.27        1.03--1.57     0.026
  Gender                                     23.2                  \<0.001                                            
   Male                          86.5%                                                     Reference                  
   Female                        90.9%                                                     0.88        0.74--1.05     0.145
  Median household income                    468.0                 \<0.001                                            
   Quartile 1                    88.7%                                                     Reference                  
   Quartile 2                    90.3%                                                     0.80        0.77--0.84     \<0.001
   Quartile 3                    91.8%                                                     1.00        0.97--1.04     0.846
   Quartile 4                    93.0%                                                     1.04        1.00--1.07     0.067
  Insurance                                  304.8                 \<0.001                                            
   Uninsured                     81.3%                                                     Reference                  
   Insured                       91.1%                                                     0.74        0.67--0.81     \<0.001
  Grade                                      5565.4                \<0.001                                            
   I                             98.2%                                                     Reference                  
   II                            93.7%                                                     2.01        1.82--2.22     \<0.001
   III                           83.9%                                                     3.71        3.36--4.10     \<0.001
  Stage                                      38639.6               \<0.001                                            
   I                             97.9%                                                     Reference                  
   II                            91.2%                                                     2.93        2.74--3.12     \<0.001
   III                           75.2%                                                     8.98        8.37--9.63     \<0.001
   IV                            35.7%                                                     24.52       22.72--26.47   \<0.001
  Subtype                                    4705.1                \<0.001                                            
   HR−/HER2− (triple negative)   79.1%                                                     Reference                  
   HR−/HER2+ (HER2 enriched)     85.6%                                                     0.43        0.40--0.47     \<0.001
   HR+/HER2− (Luminal A)         93.5%                                                     0.41        0.39--0.43     \<0.001
   HR+/HER2+ (Luminal B)         90.9%                                                     0.32        0.30--0.34     \<0.001
  Surgery                                    19591.4               \<0.001                                            
   No surgery                    51.9%                                                     Reference                  
   BCS                           95.7%                                                     0.33        0.31--0.36     \<0.001
   Mastectomy                    88.7%                                                     0.45        0.42--0.47     \<0.001
  Radiation                                  922.3                 \<0.001                                            
   None/unknown                  88.5%                                                     Reference                  
   Yes                           92.8%                                                     0.86        0.82--0.89     \<0.001
  Chemotherapy                               1605.0                \<0.001                                            
   No/unknown                    94.0%                                                     Reference                  
   Yes                           87.3%                                                     0.85        0.82--0.90     \<0.001

BCSS -- breast cancer-specific survival; PSM -- propensity score matching; HR -- hazard ratio; CI -- confidence interval.

###### 

Patient baseline characteristics after PSM.

  Characteristic                 Divorced (%)   Married (%)    P value   Single (%)     Married (%)    P value   Widowed (%)    Married (%)    P value
  ------------------------------ -------------- -------------- --------- -------------- -------------- --------- -------------- -------------- ---------
  Age                                                                                                                                          
   18--49                        4653 (20.4)    4734 (20.8)    0.744     440 (2.3)      440 (2.3)      0.958     440 (2.3)      440 (2.3)      0.958
   50--59                        6625 (29.1)    6642 (29.2)              1718 (9.0)     1728 (9.0)               1718 (9.0)     1728 (9.0)     
   60--69                        7093 (31.2)    7093 (31.2)              5265 (27.5)    5251 (27.4)              5265 (27.5)    5251 (27.4)    
   70--79                        3425 (15.1)    3335 (14.7)              7597 (39.7)    7656 (40.0)              7597 (39.7)    7656 (40.0)    
   ≥80                           958 (4.2)      950 (4.2)                4128 (21.6)    4073 (21.3)              4128 (21.6)    4073 (21.3)    
  Race                                                                                                                                         
   White                         17685 (77.7)   17605 (77.4)   0.826     15575 (81.3)   15434 (80.6)   0.084     15575 (81.3)   15434 (80.6)   0.084
   Black                         3530 (15.5)    3582 (15.7)              1957 (10.2)    2081 (10.9)              1957 (10.2)    2081 (10.9)    
   API                           1380 (6.1)     1410 (6.2)               1492 (7.8)     1529 (8.0)               1492 (7.8)     1529 (8.0)     
   AI                            159 (0.7)      157 (0.7)                124 (0.6)      104 (0.5)                124 (0.6)      104 (0.5)      
  Gender                                                                                                                                       
   Male                          113 (0.5)      112 (0.5)      1.000     83 (0.4)       74 (0.4)       0.522     83 (0.4)       74 (0.4)       0.522
   Female                        22641 (99.5)   22642 (99.5)             19065 (99.6)   19074 (99.6)             19065 (99.6)   19074 (99.6)   
  Median household income                                                                                                                      
   Quartile 1                    6606 (29.0)    6592 (29.0)    0.989     5905 (30.8)    5887 (30.7)    0.195     5905 (30.8)    5887 (30.7)    0.195
   Quartile 2                    5534 (24.3)    5512 (24.2)              4628 (24.2)    4590 (24.0)              4628 (24.2)    4590 (24.0)    
   Quartile 3                    5623 (24.7)    5638 (24.8)              4493 (23.5)    4385 (22.9)              4493 (23.5)    4385 (22.9)    
   Quartile 4                    4991 (21.9)    5012 (22.0)              4122 (21.5)    4286 (22.4)              4122 (21.5)    4286 (22.4)    
  Insurance                                                                                                                                    
   Uninsured                     500 (2.2)      501 (2.2)      1.000     180 (0.9)      185 (1.0)      0.833     180 (0.9)      185 (1.0)      0.833
   Insured                       22254 (97.8)   22253 (97.8)             18968 (99.1)   18963 (99.0)             18968 (99.1)   18963 (99.0)   
  Grade                                                                                                                                        
   I                             4634 (20.4)    4602 (20.2)    0.917     4350 (22.7)    4300 (22.5)    0.144     4350 (22.7)    4300 (22.5)    0.144
   II                            9265 (40.7)    9264 (40.7)              8514 (44.5)    8383 (43.8)              8514 (44.5)    8383 (43.8)    
   III                           8855 (38.9)    8888 (39.1)              6284 (32.8)    6465 (33.8)              6284 (32.8)    6465 (33.8)    
  Stage                                                                                                                                        
   I                             11345 (49.9)   11360 (49.9)   0.973     10544 (55.1)   10561 (55.2)   0.944     10544 (55.1)   10561 (55.2)   0.944
   II                            7853 (34.5)    7821 (34.4)              6021 (31.4)    5978 (31.2)              6021 (31.4)    5978 (31.2)    
   III                           2634 (11.6)    2659 (11.7)              1830 (9.6)     1858 (9.7)               1830 (9.6)     1858 (9.7)     
   IV                            922 (4.1)      914 (4.0)                753 (3.9)      751 (3.9)                753 (3.9)      751 (3.9)      
  Subtype                                                                                                                                      
   HR−/HER2− (triple negative)   3079 (13.5)    3111 (13.7)    0.871     2177 (11.4)    2256 (11.8)    0.151     2177 (11.4)    2256 (11.8)    0.151
   HR−/HER2+ (HER2 enriched)     1214 (5.3)     1178 (5.2)               902 (4.7)      925 (4.8)                902 (4.7)      925 (4.8)      
   HR+/HER2− (Luminal A)         15769 (69.3)   15771 (69.3)             14259 (74.5)   14065 (73.5)             14259 (74.5)   14065 (73.5)   
   HR+/HER2+ (Luminal B)         2692 (11.8)    2694 (11.8)              1810 (9.5)     1902 (9.9)               1810 (9.5)     1902 (9.9)     
  Surgery                                                                                                                                      
   No surgery                    1303 (5.7)     1294 (5.7)     0.983     1227 (6.4)     1186 (6.2)     0.197     1227 (6.4)     1186 (6.2)     0.197
   BCS                           12814 (56.3)   12815 (56.3)             11428 (59.7)   11598 (60.6)             11428 (59.7)   11598 (60.6)   
   Mastectomy                    8637 (38.0)    8645 (38.0)              6493 (33.9)    6364 (33.2)              6493 (33.9)    6364 (33.2)    
  Radiation                                                                                                                                    
   None/unknown                  10237 (45.0)   10282 (45.2)   0.678     9507 (49.7)    9593 (50.1)    0.385     9507 (49.7)    9593 (50.1)    0.385
   Yes                           12517 (55.0)   12472 (54.8)             9641 (50.3)    9555 (49.9)              9641 (50.3)    9555 (49.9)    
  Chemotherapy                                                                                                                                 
   No/unknown                    12022 (52.8)   11956 (52.5)   0.542     13528 (70.6)   13479 (70.4)   0.591     13528 (70.6)   13479 (70.4)   0.591
   Yes                           10732 (47.2)   10798 (47.5)             5620 (29.4)    5669 (29.6)              5620 (29.4)    5669 (29.6)    

PSM -- propensity score matching.
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